苯肼,硫酸盐结构式
|
常用名 | 苯肼,硫酸盐 | 英文名 | Phenelzine (sulfate) |
---|---|---|---|---|
CAS号 | 156-51-4 | 分子量 | 234.27300 | |
密度 | N/A | 沸点 | 497.4ºC at 760 mmHg | |
分子式 | C8H14N2O4S | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | 254.6ºC | |
符号 |
GHS06 |
信号词 | Danger |
苯肼,硫酸盐用途Phenelzine硫酸盐是一种非选择性和不可逆的单胺氧化酶抑制剂 (MAOI), 用作抗抑郁药和抗焦虑药。 |
中文名 | 苯肼,硫酸盐 |
---|---|
英文名 | Phenelzine hydrogen sulphate |
中文别名 | 硫酸苯乙肼 |
英文别名 | 更多 |
沸点 | 497.4ºC at 760 mmHg |
---|---|
分子式 | C8H14N2O4S |
分子量 | 234.27300 |
闪点 | 254.6ºC |
精确质量 | 234.06700 |
PSA | 121.03000 |
LogP | 2.21160 |
蒸汽压 | 1.04E-10mmHg at 25°C |
储存条件 | 2-8℃ |
水溶解性 | Freely soluble in water; practically insoluble in ethanol (96%) and in ether . |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:4 3.氢键受体数量:6 4.可旋转化学键数量:3 5.互变异构体数量:无 6.拓扑分子极性表面积121 7.重原子数量:15 8.表面电荷:0 9.复杂度:159 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2 |
更多 | 1.熔点(ºC):166.5~171 |
符号 |
GHS06 |
---|---|
信号词 | Danger |
危害声明 | H301 |
警示性声明 | Missing Phrase - N15.00950417 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
危害码 (欧洲) | Xn |
风险声明 (欧洲) | R22 |
危险品运输编码 | UN 2811 6.1/PG 3 |
WGK德国 | 3 |
RTECS号 | MV8750000 |
包装等级 | III |
危险类别 | 6.1(b) |
海关编码 | 2928000090 |
海关编码 | 2928000090 |
---|---|
中文概述 | 2928000090 其他肼(联氨)及胲(羟胺)的有机衍生物。监管条件:无。增值税率:17.0%。退税率:9.0%。最惠国关税:6.5%。普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途 |
Summary | 2928000090 other organic derivatives of hydrazine or of hydroxylamine VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Biol. Psychiatry 34(6) , 1467-81, (2009) Previous work has shown that repeated desipramine treatment causes downregulation of the norepinephrine transporter (NET) and persistent antidepressant-like effects on behavior, ie effects observed 2 ... |
|
Monoamine oxidase inhibitors revisited: what you should know.
J. Clin. Psychiatry 74(2) , 189-91, (2013)
|
|
Potential repurposing of known drugs as potent bacterial β-glucuronidase inhibitors.
J. Biomol. Screen. 17(7) , 957-65, (2012) The active metabolite of the chemotherapeutic irinotecan, SN-38, is detoxified through glucuronidation and then excreted into the gastrointestinal tract. Intestinal bacteria convert the glucuronidated... |
EINECS 205-856-0 |
2-phenylethylhydrazine,sulfuric acid |
Phenelzine sulfate salt |
Phenelzine Sulfate |
PHENETHYLHYDRAZINE SULFATE |
MFCD00050687 |
Phenelzine (sulfate) |